Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.19 AUD | +2.34% | -0.45% | +32.33% |
Mar. 04 | Polynovo Gets India OK for Listing of Dermal Scaffold Device on Government e-Portal Marketplace | MT |
Feb. 27 | Transcript : PolyNovo Limited, H1 2024 Earnings Call, Feb 27, 2024 |
Sales 2024 * | 103M 66.86M | Sales 2025 * | 133M 86.81M | Capitalization | 1.51B 984M |
---|---|---|---|---|---|
Net income 2024 * | 3M 1.95M | Net income 2025 * | 13M 8.47M | EV / Sales 2024 * | 14.3 x |
Net cash position 2024 * | 42.64M 27.76M | Net cash position 2025 * | 37.06M 24.13M | EV / Sales 2025 * | 11.1 x |
P/E ratio 2024 * |
363
x | P/E ratio 2025 * |
112
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.66% |
Latest transcript on PolyNovo Limited
1 day | +2.34% | ||
1 week | -0.45% | ||
Current month | -3.95% | ||
1 month | +2.82% | ||
3 months | +31.14% | ||
6 months | +65.91% | ||
Current year | +32.33% |
Managers | Title | Age | Since |
---|---|---|---|
Swami Raote
CEO | Chief Executive Officer | - | 22-07-28 |
Director of Finance/CFO | - | 18-12-11 | |
Philip Scorgie
CTO | Chief Tech/Sci/R&D Officer | - | 23-05-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 70 | 14-02-27 | |
Bruce Rathie
BRD | Director/Board Member | 68 | 10-02-17 |
Chief Tech/Sci/R&D Officer | - | 12-08-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 735 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - | |
0.00% | 7 M€ | +4.29% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 2.19 | +2.34% | 1,108,859 |
24-03-27 | 2.14 | +1.90% | 1,793,957 |
24-03-26 | 2.1 | -0.94% | 6,338,523 |
24-03-25 | 2.12 | -0.47% | 2,646,839 |
24-03-22 | 2.13 | -3.18% | 1,118,356 |
Delayed Quote Australian S.E., March 28, 2024 at 01:10 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.33% | 986M | |
+3.26% | 197B | |
+5.79% | 116B | |
+1.48% | 71.49B | |
+11.77% | 53.47B | |
+18.31% | 48.42B | |
+6.33% | 43.64B | |
+12.38% | 28.97B | |
+9.76% | 28.47B | |
+10.35% | 27.78B |